Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127398311 | 12739831 | 1 | I | 20160815 | 20160913 | 20160913 | EXP | FI-PFIZER INC-2016388128 | PFIZER | 72.00 | YR | F | Y | 0.00000 | 20160913 | CN | FI | FI |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127398311 | 12739831 | 1 | PS | AROMASIN | EXEMESTANE | 1 | 25 MG, DAILY | 601CC | 20753 | 25 | MG | COATED TABLET | |||||||
127398311 | 12739831 | 2 | C | AMARYL | GLIMEPIRIDE | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127398311 | 12739831 | 1 | Neoplasm malignant |
127398311 | 12739831 | 2 | Diabetes mellitus |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127398311 | 12739831 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127398311 | 12739831 | Blood glucose fluctuation | |
127398311 | 12739831 | Blood pressure fluctuation | |
127398311 | 12739831 | Headache | |
127398311 | 12739831 | Hypoaesthesia | |
127398311 | 12739831 | Pain in extremity | |
127398311 | 12739831 | Peripheral swelling | |
127398311 | 12739831 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127398311 | 12739831 | 1 | 20160804 | 20160810 | 0 |